AbbVie Tshuag: AbbVie Leans Ntawm Immunology Tshuaj Raws li Covid Slams Kev Zoo Nkauj

AbbVie (ABBV) leaned hnyav rau cov tshuaj tiv thaiv kab mob hauv lub quarter thib ob, pab txo qis rau nws cov tshuaj kho mob qog noj ntshav loj tshaj plaws thiab ntau yam kev kho kom zoo nkauj. Tab sis AbbVie Tshuag poob thaum ntxov hnub Friday.

X

Tag nrho peb ntawm AbbVieCov tshuaj tiv thaiv kab mob - Humira, Skyrizi thiab Rinvoq - tau pom nyob rau lub quarter thib ob. Cov tshuaj no kho cov mob xws li mob caj dab thiab psoriasis. Humira, uas tsis ntev los no yuav ntsib cov neeg sib tw hauv Teb Chaws Asmeskas, pom kev muag khoom nce ze li 6% ntawm qhov nruj, raws li qhia hauv paus rau $ 5.36 billion. Humira suav txog ntau tshaj li ib feem peb ntawm AbbVie cov nyiaj tau los tag nrho hauv lub quarter.

Tab sis AbbVie tau tshaj tawm kev poob qis rau nws txoj kev kho mob qog noj ntshav qab zib thiab butter, Imbruvica, thiab kev kho kom zoo nkauj rau cov tawv nqaij hu ua Juvederm.

"Qee qhov tso thiab siv thoob plaws lub rooj tsavxwm, nrog lub zog los ntawm kev tiv thaiv kab mob franchise offset los ntawm kev qaug zog los ntawm kev zoo nkauj thiab hematology / oncology franchises," Piper Sandler tus kws tshuaj ntsuam Christopher Raymond tau hais hauv tsab ntawv ceeb toom rau cov neeg siv khoom. Nws khaws nws qhov hnyav hnyav ntawm AbbVie Tshuag, txawm li cas los xij.

AbbVie Tshuag: Immunology Muag Rocket

Zuag qhia tag nrho, AbbVie qhov muag tau nce 4.5% rau $ 14.58 billion. Raws li ntau cov ntaub ntawv, cov kws tshuaj ntsuam xav tias kwv yees li ntawm $ 14.59 billion rau $ 14.67 billion hauv kev muag khoom. Cov nyiaj tau los kho tau nce txog 11% rau $ 3.37 ib feem. Qhov ntawd yeej FactSet-polled analysts 'view rau $3.28.

Qhov tseem ceeb, Rinvoq thiab Skyrizi tacked ntawm kev muag khoom muaj zog. AbbVie vam tias cov duo yuav pab tsim qhov muag pitfall thaum generic Humira hits Asmeskas lag luam xyoo tom ntej. Rinvoq muag tau nce ntau dua 56% rau $ 592 lab. Skyrizi tsim tau $ 1.25 billion, loj hlob txog 86%.

Tab sis Imbruvica muag skidded roughly 17% rau $1.15 billion. Qhov ntawd plam kev kwv yees rau $ 1.28 nphom, Piper Sandler's Raymond tau hais. AbbVie's lwm cov tshuaj mob qog noj ntshav, Venclexta, coj hauv $ 505 lab, nce txog 16%. Tab sis qhov ntawd poob qhov kev cia siab los ntawm 6%, SVB Securities tus kws tshuaj ntsuam David Risinger tau hais hauv nws daim ntawv rau cov neeg siv khoom.

Tag nrho cov kev muag khoom zoo nkauj tau poob ntau dua 4% rau $ 1.37 billion thiab plam qhov kev kwv yees los ntawm 10%, Risinger tau hais. Nws hais txog kev kaw haujlwm hauv Suav teb thiab ncua kev ua haujlwm hauv Russia. Kev muag khoom ntawm AbbVie's flagship aesthetic tshuaj, Botox, nce 19% rau $ 695 lab. Qhov no topped projections.

Rau lub xyoo, AbbVie tau lees paub nws cov nyiaj khwv tau los ntawm $ 13.78- $ 13.98 ib feem. AbbVie cov kws tshuaj ntsuam xyuas tau kwv yees kho cov nyiaj tau los ntawm $ 13.73 ib feem thiab $ 58.82 nphom hauv kev muag khoom.

Nyob rau hauv premarket trading ntawm hnub no lub khw lag luam, AbbVie Tshuag poob 1% ze 147.50.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Edwards ua raws li kev sib tw, txiav kev taw qhia raws li txiaj, Covid hnyav ntawm kev lag luam

Merck Dives Raws li Cov Nqi Them Nqi Tshuaj Txhaum Cai txo cov txiaj ntsig thib ob ntawm peb lub hlis twg

Cov Kev Xaiv Ua Lag Luam: Yuav Pib Siv Cov Kev Xaiv, Yuav Ua Li Cas Tswj Cov Kev Nyab Xeeb

Kawm Yuav Sij Hawm Li Cas Kev Ua Lag Luam Nrog IBD Txoj Kev Lag Luam Li ETF

MarketSmith: Tshawb Fawb, Cov Ntawv Cim, Cov Ntaub Ntawv Thiab Qhia Hauv Ib Qhov Chaw